Pharmaceutical enterprises of the Technopolis Moscow Special Economic Zone (SEZ) introduced 37 new drugs to the market in 2024, including drugs for the treatment of cancer, multiple sclerosis, chronic ...

Promomed is working on the next generation of a domestic drug for obesity and diabetes in tablets, as reported to TASS by the biopharmaceutical company. Last week, American Eli Lilly announced the ...

In January-March, pharmacy chains throughout the country sold 20 million packages of antihistamines used for allergies, 2.4% less than last year. For comparison, in the first quarter of 2024, natural ...

The Ministry of Health of the Russian Federation has announced the registration of Sapropterin PSK, the first Russian drug based on sapropterin, a synthetic cofactor used in the treatment of ...

The injection cosmetology market is growing. In 2024, 8,7 million such procedures were performed in Russia, and by the end of 2025, their number may grow by 15-20%, analysts predict. However, up to ...

The Russian Ministry of Health canceled the registration certificates for several drugs in mid-April, including Revlimid (lenalidomide) and Imnovid (pomalidomide), both treatments for blood cancer.

The Russian Ministry of Health has registered the drug Forsedeno (INN denosumab), the first domestic biosimilar of an original targeted drug for the treatment of osteoporosis. Petrovax Pharm is the ...

Biocad, a Russian biotechnology company, has filed registration documents for Russia’s first original gene therapy drug aimed at treating hemophilia B, a rare hereditary disorder that affects blood ...

PSK Pharma has registered Respiforb Air, a combination of budesonide and formoterol, for the treatment of bronchial asthma. The drug called Respiforb Air will be produced at the company’s own ...

The National Association of Experts in the Field of Primary Immunodeficiencies shared the results of a study evaluating the effectiveness of subcutaneous immunoglobulin administration in patients with ...

Specialists from the Peoples’ Friendship University of Russia (RUDN) have begun preclinical trials of a new drug for dementia that can not only relieve symptoms, but also restore impaired cognitive ...

According to experts, in 5 years, half of the world’s population will suffer from various allergy symptoms. The prevalence of the disease is increasing due to stress, environmental pollution and the ...